- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06489366
Efficacy of Semi-rigid Ureteroscopic Laser Lithotripsy in the Treatment of Proximal Ureteral Stones: a Randomized Controlled Trial
June 28, 2024 updated by: Zhongnan Hospital
The efficacy of Ho: YAG and TFL combined with semirigid ureteroscopic treatment of proximal ureteral stones will be compared.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The target population of this study is patients with proximal ureteral stones who are scheduled to undergo semirigid ureteroscopic laser lithotripsy.
After enrollment, the subjects will be randomly assigned to the semirigid ureteroscopic holmium laser (Ho: YAG) lithotripsy group and the semirigid ureteroscopic thulium fiber laser (TFL) lithotripsy group for surgical treatment.
The subjects will be followed up after surgery, and the collected data will be summarized and analyzed after the study.
Study Type
Interventional
Enrollment (Estimated)
138
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xinghuan Wang
- Phone Number: +86 18770426026
- Email: wangxinghuan@whu.edu.cn
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430071
- Zhongnan Hospital, Wuhan University,
-
Contact:
- Xinghuan Wang
- Phone Number: +86 18770426026
- Email: wangxinghuan@whu.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- ≥18 years old;
- patients diagnosed with unilateral proximal ureteral stones ≤2cm by computed tomography (CT)/Kidney and upper bladder (KUB) radiography who required surgery;
- patients who volunteered to participate in this study.
Exclusion Criteria:
- Unable to give informed consent;
- Untreated urinary tract infection;
- Pregnant women;
- Known anatomical abnormalities (such as urinary diversion or ureteral stenosis);
- Urothelial tumors, transplanted kidney stones, irreversible coagulopathy;
- The semi-rigid ureteroscope cannot reach the stone site, ureteroscopy-negative stones, and stones can be removed directly without laser lithotripsy;
- The researchers believe that they are not suitable for participation in this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Ho: YAG lithotripsy
Ho; YAG laser therapy device is used.
The patient adopts lithotomy position.
After general anesthesia, a semi-rigid ureteroscope is used to enter the bladder through the urethra to observe the ureteral opening, and then a hydrophilic guide wire is inserted into the ureter on the affected side.
After the semi-rigid ureteroscope slowly enters along the hydrophilic guide wire and reaches the bottom of the stone, the laser optical fiber of the laser therapy device is inserted into the working channel of the ureteroscope so that the end of the optical fiber is exposed in the field of view of the ureteroscope.
After the laser therapy device sets the lithotripsy parameters, the optical fiber is aimed at the stone for laser lithotripsy.
|
Ho:YAG laser lithotripsy was used in patients with proximal ureteral stones undergoing ureteroscopic lithotripsy.
|
|
Experimental: Thulium Fiber laser (TFL) lithotripsy
The patient adopts lithotomy position.
After general anesthesia, a semi-rigid ureteroscope is used to enter the bladder through the urethra to observe the ureteral opening, and then a hydrophilic guide wire is inserted into the ureter on the affected side.
After the semi-rigid ureteroscope slowly enters along the hydrophilic guide wire and reaches the bottom of the stone, the laser fiber of the laser therapy machine is inserted into the working channel of the ureteroscope so that the end of the fiber is exposed to the field of view of the ureteroscope.
Using the TFL laser therapy device, after setting the lithotripsy parameters, the fiber is aimed at the stone for laser lithotripsy.
|
Patients with proximal ureteral stones undergoing ureteroscopic lithotripsy using thulium laser lithotripsy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stone-free rate (SFR)
Time Frame: 2-4 weeks after surgery
|
Stone-free rate (SFR) after single-session laser lithotripsy using a semirigid ureteroscope without an auxiliary procedure assessed by CT/X-ray at 2-4 weeks follow-up after laser lithotripsy.
|
2-4 weeks after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative time
Time Frame: Immediately during surgery
|
the time of laser lithotripsy
|
Immediately during surgery
|
|
Intraoperative complications
Time Frame: Immediately during surgery
|
bleeding, ureteral perforation, ureteral wall injury, or intraoperative adverse events leading to termination of surgery
|
Immediately during surgery
|
|
Postoperative complications
Time Frame: 2-4 weeks after surgery
|
Occurrence of postoperative complications
|
2-4 weeks after surgery
|
|
Additional procedures
Time Frame: Intraoperatively and before removal of the Ureteral stents
|
If semi-rigid ureteroscopy combined with laser lithotripsy fails, it is converted to flexible ureteroscopy, PCNL, laparoscopic lithotomy.
In addition, ESWL treatment is performed before the double-J stent is removed after surgery.lithotripsy,
and postoperative ESWL treatment before removal of the ureteral stents, among others.
|
Intraoperatively and before removal of the Ureteral stents
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 26, 2024
Primary Completion (Estimated)
January 26, 2025
Study Completion (Estimated)
February 26, 2025
Study Registration Dates
First Submitted
June 28, 2024
First Submitted That Met QC Criteria
June 28, 2024
First Posted (Actual)
July 5, 2024
Study Record Updates
Last Update Posted (Actual)
July 5, 2024
Last Update Submitted That Met QC Criteria
June 28, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20240173
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urolithiasis
-
Beni-Suef UniversityRecruiting
-
Singapore General HospitalUnknown
-
Kırıkkale UniversityCompletedKidney Calculi Nephrolithiasis Urolithiasis Renal Stone
-
University of Sao Paulo General HospitalCompletedUrolithiasis and Aging | Renal Calcul and Metabolic Diseases | Urolithiasis and OsteoporosisBrazil
-
EULIS Colloborative Research Working GroupUnknownKidney Calculi | Nephrolithiasis | Patient Compliance | Calcium Oxalate Urolithiasis
-
Catalysis SLCompletedKidney Calculi | Kidney Injury | Urolithiasis | Ureteral Calculi | Ureteral Obstruction | Renal Disease | Renal Stone | Ureteral Injury | Renal Injury | Urolithiasis, Calcium Oxalate | Urolithiasis; Lower Urinary TractNicaragua
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingHealthy | Kidney Calculi | Nephrolithiasis | Urolithiasis | Kidney Stone | Nephrolithiasis, Calcium Oxalate | Oxaluria | Urolithiasis, Calcium Oxalate | Oxalate UrolithiasisUnited States
-
London Health Sciences Centre Research Institute...St. Joseph's Health Care LondonCompletedKidney Calculi | Nephrolithiasis | Kidney Stone | Human | Calcium Oxalate Urolithiasis | Vitamin K 2 | Calcium Oxalate Kidney Stones | Calcium Phosphate UrolithiasisCanada
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingHealthy | Kidney Calculi | Nephrolithiasis | Urolithiasis | Healthy Volunteer | Kidney Stones | Nephrolithiasis, Calcium Oxalate | Urolithiasis, Calcium Oxalate | Oxalate UrolithiasisUnited States
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingKidney Calculi | Nephrolithiasis | Urolithiasis | Kidney Stone | Nephrolithiasis, Calcium Oxalate | Oxaluria | Urolithiasis, Calcium Oxalate | Oxalate UrolithiasisUnited States
Clinical Trials on Ho: YAG lithotripsy
-
Ain Shams UniversityCompletedUrethral Stricture, MaleEgypt
-
HealOrCompletedDiabetic Foot Ulcer | Venous UlcerIsrael
-
The Cleveland ClinicCompleted
-
Hainan Province Liu Zhongmin Expert Team Innovation...Completed
-
Universiti Putra MalaysiaCompletedDepressive Symptoms | Anxiety State | Motivation | Psychological StressMalaysia
-
Mahidol UniversitySiriraj Hospital, Mahidol University, Bangkok, Thailand.Recruiting
-
Panbela Therapeutics, Inc.CompletedPancreatic Cancer | Ductal Adenocarcinoma of the PancreasUnited States, Australia
-
Instituto PalaciosCompleted
-
HealOrCato Research; Clinigene International LtdUnknownDiabetic Foot UlcerUnited States, India
-
Shockwave Medical, Inc.Massachusetts General Hospital; Yale University; IQVIA Pty LtdActive, not recruitingPeripheral Arterial DiseaseJapan